Scientific Board


Process Analytical Technology is one of the most exciting and important advanced technology areas meeting both the current challenges, as well as the future needs of industry. Since 1987, the IFPAC conferences have generated the enthusiastic response that resulted in the creation of a series of International meetings featuring the regulators, manufacturers, researchers and industry users.  Equipment and services are typically on display during our events.

So please join us...meet with your colleagues...the people who are the foundation of Process Analytical Technology (PAT), QbD, Process Understanding & Control, and Real-Time Analytics. Come share in discussions, give input and get ideas for the future well-being of the industry.

 

IFPAC - 2019 SCIENTIFIC BOARD

Co-Chairs

David Keire, FDA, CDER, OPQ, OTR, Silver Spring, MD

Cenk Undey, Amgen, Thousand Oaks, CA

Bob Bear, Ametek, Berwyn, PA

 

Members

Scott Armstrong, ExxonMobil, Baton Rouge, LA
Lucinda Buhse, FDA, CDER, OPQ, OTR, DPA, St. Louis, MO
Sharmista Chatterjee, FDA, CDER, OPQ, OPF, Silver Spring, MD
James Cheney, Celgene, Summit, NJ

John Coates, Coates Consulting
John Crandall, Falcon Analytical, Ronceverte, WV 

Celia Cruz, FDA/CDER/OPQ/OTR, Silver Spring, MD
Rick Friedman, FDA, CDER, OC, OMQ, Silver Spring, MD
Steve Hammond, Consultant
Walter Henslee, JPAC, McDade, TX  

Ernie Hillier, Waters Corporation, Milford, MA

Rabih Jabbour, U.S. Army, APG
Mel Koch, APL, Univ. of Washington, Seattle, WA
Evdokia Korakianiti, EMA
Theodora Kourti, Consultant
Steve Kozlowski, FDA, CDER, OPQ, OBP, Silver Spring, MD
Mark A. LaPack, Consultant
Sau (Larry) Lee, FDA/CDER/OMPT/CDER/OPQ/SS, Silver Spring, MD 

Lorenz Liesum, Novartis Pharma, Basel, Switzerland
Matthew H. MacConnell, Air Products and Chemicals, Allentown, PA 

Rapti Madurawe, FDA/CDER/OPQ/OPF/DPAI, Silver Spring, MD

Jose Cardoso de Menezes, IST, UTL, Lisbon, Portugal
Sarah Pope Miksinski, AstraZeneca, Gaithersburg, MD
Christine M. Moore, Merck, West Point, PA
Fernando Muzzio, Rutgers University, New Brunswick, NJ
Moheb M. Nasr, Consultant
G. K. Raju, Light Pharma, Cambridge, MA
Manoharan Ramasamy, Merck & Co., West Point, PA

Brian Rohrback, Infometrix, Inc., Bothell, WA

Saly Romero-Torres, Biogen, RTP, NC

Sonja S. Sekulic, Pfizer, Groton, CT 

Robert E. Sherman, ISA Fellow; Process Control Consultant, Shorewood, IL

Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate, Dow Chemical, Freeport, TX
Gert Thurau, Hoffmann-LaRoche, Basel, Switzerland
Paul Vahey, The Boeing Company, Boeing Research and Technology, Seattle, WA   

Juergen von Frese, Da-Sol, Utting am Ammersee, Germany
Martin Warman, Martin Warman Consultancy, Swalecliffe, UK   

Xiaoyu Zhang, Eli Lilly, Indianapolis, IN

 

Organization Representatives

Stephen Byrn, CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson, DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt, Director, CPAC, APL, Univ. of Washington, Seattle, WA

Antonio Moreira, University of Maryland - Baltimore County
Fernando Muzzio, Rutgers University, New Brunswick, NJ

Rodolfo Romañach, Ph.D., UPR, Mayagüez, PR,
Michael J. Tarlov, NIST, Gaithersburg, MD

 

IFPAC Director

Robert S. Zutkis, IFPAC, Grayslake, IL

Conference Management Software by X-CD Technologies Inc.